iRhythm Technologies, a provider of cardiac rhythm monitoring solutions for the healthcare industry, has raised $16 million in Series D financing led by Norwest Venture Partners, with participation from existing investors New Leaf Venture Partners, Synergy Life Science Partners and Kaiser Permanente Ventures. The San Francisco-based company will use the new capital to fund commercial expansion and accelerate the development of new technologies and applications. iRhythm's solutions are designed to facilitate early diagnosis and treatment decisions, with the goal of improving patient health outcomes and reducing wasteful spending. In conjunction with the financing, NVP’s Casper de Clercq has joined the company’s Board.
